Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03397862 · ClinicalTrials.gov registry record · Phase 1
A Skin Irritation Assessment of Once-Weekly Corplex™ Donepezil Transdermal Delivery System
A Phase 1 study, sponsored by Corium.
- Completed
- Registry status
- Phase 1
- Development phase
- 256
- Enrollment target
NCT03397862 is a Phase 1 study that has completed, run by Corium. The registered enrollment target is 256 participants.
The verdict
NCT03397862, a Phase 1 study, has completed, sponsored by Corium.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 256 participants
- Enrollment target
Study Summary
A study to assess the skin irritation and sensitization potential of Corplex™ Donepezil Transdermal Delivery System (TDS)
Interventions
- DRUG Donepezil TDS
- DRUG Vehicle TDS
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 256 participants |
| Start Date | 2017-11-14 |
| Est. Completion | 2018-04-02 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03397862
The ClinicalTrials.gov registry entry for NCT03397862 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 256 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Corium, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Donepezil TDS is the first listed.
NCT03397862 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03397862 about?
NCT03397862 is a clinical study titled "A Skin Irritation Assessment of Once-Weekly Corplex™ Donepezil Transdermal Delivery System". A study to assess the skin irritation and sensitization potential of Corplex™ Donepezil Transdermal Delivery System (TDS)
What is the current status of trial NCT03397862?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 256 participants. The study started on 2017-11-14. Estimated completion is 2018-04-02.
What interventions are being tested in trial NCT03397862?
The interventions under investigation include: Donepezil TDS (DRUG), Vehicle TDS (DRUG).
Who is sponsoring clinical trial NCT03397862?
This trial is sponsored by Corium, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.